丁苯酞胶囊不同剂量对急性脑梗死患者神经功能重建的影响

doi:10.3969/j.issn.1001-8131.2025.06.014

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (572 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the dynamic impact mechanism of different doses of Butylphthalide capsules on neural function recovery in patients with acute cerebral infarction. Methods This study included 120 patients with acute cerebral infarction admitted to our hospital's neurology department from January 2022 to January 2025.They were randomly assigned to a high-dose group(60 cases)and a low-dose group(60 cases)using a coin toss method.On the basis of conventional treatment,the high-dose group was given 200 mg of Butylphthalide soft capsules,while the low-dose group received 100 mg.The efficacy,hemorheological parameters,neurological function recovery,neuroregeneration factor levels,and adverse reactions were compared between the two groups. Results The clinical efficacy rate in the high-dose group(91.11%)was higher than that in the low-dose group(80.00%).After treatment,the erythrocyte aggregation index(2.32±0.44),whole blood viscosity(4.36±0.81 mPa.s),and plasma viscosity(1.44±0.42mPa.s)in the high-dose group were significantly lower than those in the low-dose group(P<0.05).The modified Rankin Scale(mRS)score in the high-dose group(1.98±0.68)was also significantly lower(P<0.05).Furthermore,the levels of brain-derived neurotrophic factor(BDNF)(3.50±1.28ng/L),nerve growth factor(NGF)(710.72±108.60ng/L),and gamma-aminobutyric acid(GABA)(4.26±0.74 μmol/L)in the high-dose group were significantly higher(P<0.05).Regarding adverse drug reactions,the incidence was 3.33% in the high-dose group,which was not statistically different from the low-dose group(P>0.05). Conclusion High-dose Butylphthalide capsules demonstrate better efficacy in treating acute cerebral infarction,significantly improving hemorheological parameters,promoting neurological function recovery,enhancing neuroregeneration-related factors,and showing a favorable safety profile.

Key words： Butylphthalide Capsules Different Doses Acute Cerebral Infarction Neurological Function Recovery

Received: 08 August 2025

PACS:

R743.3

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Chu Panpan
	Zhang Deen
	Wang Xuan
	Chang Weina

Cite this article:

Chu Panpan,Zhang Deen,Wang Xuan, et al. Effect of Different Doses of Buterphthalin Capsules on Neurological Reconstruction in Patients with Acute Cerebral Infarction[J]. journal1, 2025, 45(6): 51-54.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2025.06.014 OR http://www.hrbyybjb.org.cn/EN/Y2025/V45/I6/51

[1] 刘意,金东辉,殷蕾,等.2017-2020年湖南省40岁及以上居民脑卒中流行趋势分析[J].实用预防医学,2024(12).
[2] 《中国脑卒中防治报告2021》编写组,王陇德.《中国脑卒中防治报告2021》概要[J].中国脑血管病杂志,2023,20(11):783-792.
[3] 郭宏伟,刘迪龑,胡义奎,等.初发脑梗死患者血小板内皮聚集受体1基因多态性与卒中后神经功能缺损和认知功能障碍的关系[J].广西医学,2021,43(11):5.
[4] 路俊芳. 阿替普酶静脉溶栓治疗对急性脑梗死患者神经功能及生活质量的影响[J].中国药物与临床,2020,20(18):2.
[5] 肖海燕,杨淑贤,韩雯,等.丁苯酞及其衍生物药理学研究进展[J].中国中药杂志,2022,47(13):3425-3431.
[6] 赵立伟. 丁苯酞对急性前循环大动脉粥样硬化性脑梗死患者脑灌注的影响研究[D].锦州医科大学,2021.
[7] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性卒中诊治指南2023[J].中华神经科杂志,2024,57(06):523-559.
[8] 李宏建. 基线NIHSS评分和闭塞部位对大脑后动脉卒中血管内治疗与药物治疗转归的影响[J].国际脑血管病杂志,2024,32(09):653-653.
[9] 陈新华. CT灌注成像对颞浅动脉-大脑中动脉搭桥术后脑血流的评估及与卡氏功能状态评分改良Rankin量表改良Barthel指数的相关性[J].山西医药杂志,2023,52(3):184-187.
[10] Lu Y,Deng J,Huang Y,et al.Spatial metabolic analysis of the regulatory effects of DL-3-n-butylphthalide in a cerebral ischemia-reperfusion mouse model[J].Neurothe-rapeutics,2025:e00530.
[11] 潘茁丽,成美芳,马静萍.丁苯酞及其衍生物在脑缺血再灌注损伤中的保护机制[J].神经损伤功能重建,2022,17(6):341-343.
[12] HouFangfang,Yan Liping,Liu Chenyang.Effect of dihydr-oergotoxine combined with ginkgo biloba extract inje-ction for elderly patients with ischemic cerebrovascular disease[J].International Medicine and Health Guidance News,2024,30(3):404-408.
[13] 白一江,王任生,白保权等.低分子肝素钙联合丁苯酞治疗脑缺血患者的临床研究[J].中国临床药理学杂志,2020(14):1935-1937+1941.
[14] 臧东运,郝建伟.脑脉泰胶囊联合丁苯酞软胶囊治疗急性脑梗死的临床研究[J].现代药物与临床,2021,36(4):676-679.
[15] 杨蓉,李寅珍,严首春.丁苯酞氯化钠注射液联合rt-PA 超时间窗溶栓治疗急性脑梗死患者的效果评价[J].中国中西医结合急救杂志,2021,28(3):316-319.
[16] 张龙,吴小燕,高金玉,等.不同剂量阿加曲班联合丁苯酞对急性脑梗死患者效果及预后的影响因素分析[J].现代生物医学进展,2024,24(12):2279-2283.
[17] 叶指南,徐浩,陈瑛,等.丁苯酞序贯治疗中青年急性脑干梗死的临床研究[J].2020年浙江省神经病学学术大会论文汇编,2025.
[18] 杨蓉,李寅珍,严首春.丁苯酞氯化钠注射液联合rt-PA 超时间窗溶栓治疗急性脑梗死患者的效果评价[J].中国中西医结合急救杂志,2021,28(3):316-319.
[19] 张龙,吴小燕,高金玉,等.不同剂量阿加曲班联合丁苯酞对急性脑梗死患者效果及预后的影响因素分析[J].现代生物医学进展,2024,24(12):2279-2283.
[20] 丁彦博,张雄智,潘燕.丁苯酞软胶囊联合阿司匹林治疗急性脑梗死的效果分析[J].中国实用医刊,2025.
[21] 崔晓,孙慧勤.丁苯酞注射液对急性脑梗死患者血清IL-6、IL-1β、TNF-α及预后的影响[J/OL].中华脑血管病杂志(电子版),2020,14(1):55-58.